药易购(300937) - 300937药易购投资者关系管理信息20250822

Group 1: Company Strategy and Market Positioning - The company is committed to the development of the out-of-hospital market and the pharmaceutical internet industry, focusing on a full-channel supply chain and driven by digital innovation technology [2][4] - As of the first half of 2025, the company has established a comprehensive SBbC ecosystem covering R&D, production, commerce, retail, and end-user channels, positioning itself as a leading enterprise in the health technology sector [4][5] Group 2: Investment Directions and Collaborations - The company has set up the Jian Su Yi Gou Fund in collaboration with professional investment institutions and state-owned platforms, aiming to identify quality enterprises and projects related to its main business [5] - Future investments will focus on acquiring quality products' pricing power through equity investments in traditional Chinese medicine and innovative pharmaceutical sales channels, including internet retail and smart drug storage [5] Group 3: TOC Business Development - The company has established Sichuan Yao Yi Gou Technology Group Co., Ltd. to enhance investments in internet pharmaceutical retail and offline channels [6] - In the first half of 2025, the company's subsidiary Chongqing Yao Da Mai generated revenue of 150 million CNY, achieving 77.73% of its total revenue for 2024, while its partner company Yu Xin Zhong Yi achieved significant recognition and revenue growth [7]